Oxford, NCNCT07222293Now EnrollingIRB Ready

Diabetic Retinopathy (DR) Clinical Trial in Oxford, NC

Access cutting-edge diabetic retinopathy (dr) treatment through this clinical trial at a research site in Oxford. Study-provided care at no cost to qualified participants.

Sponsored by Artelus AI

Quick Self-Assessment

See if you qualify for this Oxford location

Preparing your pre-screening questions…

Expert Care in Oxford

Access diabetic retinopathy (dr) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetic retinopathy (dr) treatment provided free

Apply for This Oxford Location

Check if you qualify for this diabetic retinopathy (dr) clinical trial in Oxford, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Oxford

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Oxford site if eligible
  4. 4Begin participation

About This Diabetic Retinopathy (DR) Study in Oxford

A study will be conducted to demonstrate that DRISTi will correctly diagnose Diabetic Retinopathy (e.g., mtmDR, PDR, DME) in eyes of patients with diabetes. Participants who have been diagnosed with diabetes mellitus and meet the other inclusion/exclusion criteria will be invited to participate and will consent to have ophthalmic images taken. These images will be analyzed by DRISTi AI software and evaluated by an ophthalmic reading center. The results will be compared, and a statistical analysis will be completed to ensure statistical significance in the outcomes thus proving DRISTi is an effective DR diagnosis tool.

Sponsor: Artelus AI

Who Can Participate

Inclusion Criteria

Ability to sign and date the informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Age (≥)21 years of age or older
Diagnosed with diabetes mellitus as per criteria established by the World Health Organization (WHO) or the American Diabetes Association (ADA)
Hemoglobin A1c (HbA1c) ≥ 6.5%
Fasting Plasma Glucose (FPG) ≥ 126 mg/dL (7.0 mmol/L)
Symptoms of hyperglycemia or hyperglycemic crisis with a random plasma glucose (RPG) ≥ 200 mg/dL (11.1 mmol/L)

Exclusion Criteria

Persistent visual impairment in one or both eyes;
History of macular edema or retinal vascular (vein or artery) occlusion;
History of ocular injections, laser treatment of the retina, or intraocular surgery other than cataract surgery without complications;
Subject is contraindicated for fundus photography (for example, has light sensitivity);
Subject has contraindications for mydriatic medications or is unwilling or unable to dilate;
Subject is currently enrolled in an interventional study of an investigational device or drug for the same condition; or
Subject has a condition or is in a situation which in the opinion of the Investigator, might confound study results, may interfere significantly with the subject's participation in the study, or may result in ungradable clinical reference standard photographs
Subject falls into one of the below categories:
Adults unable to consent (individuals w/ impaired decision-making capacity)
Individuals who are not yet adults (infants, children, teenagers)
Pregnant women

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Oxford?

Yes, this clinical trial (NCT07222293) has an active research site in Oxford, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetic Retinopathy (DR) Treatment Options in Oxford, NC

If you're searching for diabetic retinopathy (dr) treatment options in Oxford, NC, this clinical trial (NCT07222293) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Oxford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic retinopathy (dr) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetic retinopathy (dr) clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Oxford, NC

See all essential tremor clinical trials recruiting in Oxford — not just this study.

Browse Essential Tremor Trials in Oxford →

Browse More Trials by Condition

Essential Tremor TrialsType 2 Diabetes TrialsInterstitial Cystitis TrialsDiabetic Retinopathy TrialsAll Conditions →

Ready to Join in Oxford?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Oxford, NC